✦ LIBER ✦

Maintenance of efficacy and safety with continuous efalizumab therapy in patients with moderate to severe chronic plaque psoriasis: Final phase IIIb study results

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety and efficacy of efalizumab therap

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 55 KB

Efficacy and safety of efalizumab in pat

📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Safety and tolerability of efalizumab th

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Safety of efalizumab in adults with chro

✍ Kim A. Papp; Reni Bressinck; Scott Fretzin; Bernard Goffe; Steven Kempers; Kenne 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 204 KB

Long-term continuous efalizumab therapy

✍ Alice B. Gottlieb; Tiffani Hamilton; Ivor Caro; Paul Kwon; Peter G. Compton; Cra 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 298 KB

Long-term efficacy of up to 15 months’ e

✍ Darryl P. Toth; Kim Papp; David Gratton 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 380 KB